| [1] |
Aggarwal S,Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 2005, 105(4): 1815-1822.
|
| [2] |
Chang CJ,Yen ML,Chen YC, et al. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells, 2006, 24(11): 2466-2477.
|
| [3] |
Jones BJ,Brooke G,Atkinson K, et al. Immunosuppression by pla-cental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells. Placenta, 2007, 28(11/12): 1174-1181.
|
| [4] |
Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy, 2003, 5(6): 485-489.
|
| [5] |
Wynn RF,Hart CA,Corradi-Perini C, et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood, 2004, 104(9): 2643-2645.
|
| [6] |
Bensidhoum M,Chapel A,Francois S，et al. Homing of in vitro ex-panded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. Blood, 2004, 103(9): 3313-3319.
|
| [7] |
Devine SM,Bartholomew AM,Mahmud N, et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol, 2001, 29(2): 244-255.
|
| [8] |
Jiang Y,Jahagirdar BN,Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 2002, 418(6893): 41-49.
|
| [9] |
Meisel R,Zibert A,Laryea M, et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood, 2004, 103(12): 4619-4621.
|
| [10] |
Devine SM,Cobbs C,Jennings M, et al. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into non-human primates. Blood, 2003, 101(8): 2999-3001.
|
| [11] |
Sundin M,Barrett AJ,Ringdén O, et al. HSCT recipients have specific tolerance to MSC but not to the MSC donor. J Immunother, 2009, 32(7): 755-764.
|
| [12] |
von Bonin M,Stölzel F,Goedecke A, et al. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant, 2009, 43(3): 245-251.
|
| [13] |
Ringden O,Keating A. Mesenchymal stromal cells as treatment for chronic GVHD. Bone Marrow Transplant, 2011, 46(2): 163-164.
|
| [14] |
Itakura S,Asari S,Rawson J, et al. Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat. Am J Transplant, 2007, 7(2): 336-346.
|
| [15] |
李明,蔡德鸿,张桦,等.间充质干细胞联合骨髓细胞输注诱导胰岛移植免疫耐受的研究.解放军医学杂志, 2008, 33(3): 269-272.
|
| [16] |
Zhou B,Han ZC,Poon MC, et al. Mesenchymal stem/stromal cells(MSC) transfected with stromal derived factor 1 (SDF-1) for therapeutic neovascularization: enhancement of cell recruitment and entrapment. Med Hypotheses, 2007, 68(6): 1268-1271.
|
| [17] |
Dahlke MH,Hoogduijn M,Eggenhofer E, et al. Toward MSC in sol-id organ transplantation: 2008 position paper of the MISOT study group. Transplantation, 2009, 88(5): 614-619.
|
| [18] |
Wang Y,Abarbanell AM,Herrmann JL, et al. TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection. PLoS One, 2010, 5(12): e14206.
|
| [19] |
谭浩翔,高毅,王琼,等.骨髓间质干细胞在原位肝移植受体鼠体内分布及对肝功能和生存期的影响.中国组织工程研究与临床康复, 2007, 11(21): 4061-4065.
|
| [20] |
Kale S,Karihaloo A,Clark PR, et al. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest, 2003, 112(1): 42-49.
|
| [21] |
Lin F,Cordes K,Li L, et al. Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol, 2003, 14(5): 1188-1199.
|
| [22] |
Herrera MB,Bussolati B,Bruno S, et al. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med, 2004, 14(6): 1035-1041.
|
| [23] |
Morigi M,Imberti B,Zoja C, et al. Mesenchymal stem cells are re-notropic, helping to repair the kidney and improve function in acute re-nal failure. J Am Soc Nephrol, 2004, 15(7): 1794-1804.
|
| [24] |
Tögel F,Hu Z,Weiss K, et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol, 2005, 289(1): F31-F42.
|
| [25] |
Kunter U,Rong S,Djuric Z, et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol, 2006, 17(8): 2202-2212.
|